Abstract-There is indirect evidence for a gender difference in nitric oxide (NO) synthesis from vascular endothelium. The aim of the present study was to determine NO production more directly in healthy women and men by the measurement of 15 N nitrate excreted in urine after the intravenous administration of L-[ 15 N] 2 -guanidino arginine. Twenty-four healthy volunteers (13 men aged 22 to 40 years and 11 women aged 23 to 42 years) participated in this study. No subjects were receiving any medication. Women were studied between the 7th and 14th days of their menstrual cycles. Arterial blood pressure was measured oscillometrically, and 1.13 mol L-[ 15 N] 2 arginine was administered intravenously after an overnight fast. Urine was collected for the next 36 hours in separate 12-hour periods. Urinary 15 N/ 14 N nitrate ratio was assessed by dry combustion in an isotope ratio mass spectrometer. Mean 36-hour urinary 15 N nitrate excretion was greater in women than in men (2111Ϯ139 versus 1682Ϯ87 mol; PϽ0.05). Furthermore, total urinary 15 N nitrate excretion was associated inversely with the mean arterial blood pressure in the whole group of subjects (coefficient of correlation, 0.47; Pϭ0.022). The present data show that whole-body production of NO is greater in healthy premenopausal women than in men under ambulatory conditions. The cellular origin of NO measured in this study is unknown, but differences in endothelial production could underlie differences in vascular function between men and women. (Hypertension. 1998;32:730-734.) Key Words: endothelium-derived relaxing factor Ⅲ arginine Ⅲ nitrates Ⅲ gender Ⅲ adults P remenopausal women have less atheromatous arterial disease, including stroke or coronary artery disease, than men of similar age.1 Synthesis of nitric oxide (NO) by the endothelium regulates vascular tone in the arterial bed and modulates interactions between the endothelium and circulating blood cells, including platelets and leukocytes.2 Previous studies have suggested that a gender difference in the production of NO due to ovarian hormones (ie, estrogens) could contribute to this low risk of cardiovascular events in women of reproductive age. However, the role of NO is controversial because increased 3,4 or diminished 5,6 production in women compared with men has been reported. It is possible that the indirect nature and relative specificity of the methods used for the measurement of NO in those studies might account for these discrepancies. Measurement of urinary or serum nitrate is highly affected by diet.7 Cyclic GMP is also the second messenger of atrial natriuretic peptide, 8 and exhaled NO reflects local biosynthesis in the lung and/or upper airways rather than in the whole body. We have developed a sensitive and specific method to measure more directly the conversion of L-arginine to NO. 9 The method is based on the measurement of 15 N nitrate (stable oxidation product of NO) excretion in urine after intravenous single administration of the stable isotope L-[ 15 N] 2 -guanidino arginine. Us...
Neutrophil serine proteases (NSPs), such as neutrophil elastase (NE), are activated by dipeptidyl peptidase 1 (DPP1) during neutrophil maturation. High NSP levels can be detrimental, particularly in lung tissue, and inhibition of NSPs is therefore an interesting therapeutic opportunity in multiple lung diseases, including chronic obstructive pulmonary disease (COPD) and bronchiectasis. We conducted a randomized, placebo‐controlled, first‐in‐human study to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of single and multiple oral doses of the DPP1 inhibitor AZD7986 in healthy subjects. Pharmacokinetic and pharmacodynamic data were analyzed using nonlinear mixed effects modeling and showed that AZD7986 inhibits whole blood NE activity in an exposure‐dependent, indirect manner—consistent with in vitro and preclinical predictions. Several dose‐dependent, possibly DPP1‐related, nonserious skin findings were observed, but these were not considered to prevent further clinical development. Overall, the study results provided confidence to progress AZD7986 to phase II and supported selection of a clinically relevant dose.
Abstract-There is indirect evidence for a gender difference in nitric oxide (NO) synthesis from vascular endothelium. The aim of the present study was to determine NO production more directly in healthy women and men by the measurement of 15 N nitrate excreted in urine after the intravenous administration of L-[ 15 N] 2 -guanidino arginine. Twenty-four healthy volunteers (13 men aged 22 to 40 years and 11 women aged 23 to 42 years) participated in this study. No subjects were receiving any medication. Women were studied between the 7th and 14th days of their menstrual cycles. Arterial blood pressure was measured oscillometrically, and 1.13 mol L-[ 15 N] 2 arginine was administered intravenously after an overnight fast. Urine was collected for the next 36 hours in separate 12-hour periods. Urinary 15 N/ 14 N nitrate ratio was assessed by dry combustion in an isotope ratio mass spectrometer. Mean 36-hour urinary 15 N nitrate excretion was greater in women than in men (2111Ϯ139 versus 1682Ϯ87 mol; PϽ0.05). Furthermore, total urinary 15 N nitrate excretion was associated inversely with the mean arterial blood pressure in the whole group of subjects (coefficient of correlation, 0.47; Pϭ0.022). The present data show that whole-body production of NO is greater in healthy premenopausal women than in men under ambulatory conditions. The cellular origin of NO measured in this study is unknown, but differences in endothelial production could underlie differences in vascular function between men and women. (Hypertension. 1998;32:730-734.) Key Words: endothelium-derived relaxing factor Ⅲ arginine Ⅲ nitrates Ⅲ gender Ⅲ adults P remenopausal women have less atheromatous arterial disease, including stroke or coronary artery disease, than men of similar age.1 Synthesis of nitric oxide (NO) by the endothelium regulates vascular tone in the arterial bed and modulates interactions between the endothelium and circulating blood cells, including platelets and leukocytes.2 Previous studies have suggested that a gender difference in the production of NO due to ovarian hormones (ie, estrogens) could contribute to this low risk of cardiovascular events in women of reproductive age. However, the role of NO is controversial because increased 3,4 or diminished 5,6 production in women compared with men has been reported. It is possible that the indirect nature and relative specificity of the methods used for the measurement of NO in those studies might account for these discrepancies. Measurement of urinary or serum nitrate is highly affected by diet.7 Cyclic GMP is also the second messenger of atrial natriuretic peptide, 8 and exhaled NO reflects local biosynthesis in the lung and/or upper airways rather than in the whole body. We have developed a sensitive and specific method to measure more directly the conversion of L-arginine to NO. 9 The method is based on the measurement of 15 N nitrate (stable oxidation product of NO) excretion in urine after intravenous single administration of the stable isotope L-[ 15 N] 2 -guanidino arginine. Us...
Background-There is evidence that endogenous nitrate synthesis is notably increased in patients with infective gastroenteritis. Aims-To determine whether this is due to nitric oxide (NO) production via the L-arginine/NO pathway. (Gut 1999;45:355-361) Methods-Seven
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.